作者 Wang, Genbei; Hao, Ruijia; Liu, Yu; Wang, Yu; Man, Shuli; Gao, Wenyuan
期刊 JOURNAL OF ETHNOPHARMACOLOGY , MAR 2019,2:17
DOI 10.1016/j.joim.2019.01.006 PubMed 30738772
摘要 Ethnopharmacological relevance: Paris polyphylla var yunnanensis as a traditional Chinese medicine has been used in the treatment of liver disease for thousands of years. Rhizoma Paridis saponins (RPS) were the main active ingredients in Paris polyphylla with an excellent antitumor effect. However, metabolic and distribution of RPS has not been known.Aim of the study: The objective of this study was to research metabolic and distribution of RPS. Materials and methods: In this study, the separation and simultaneous determination of RPS in rat plasma and tissues were developed and validated by LC?MS/MS. The permeability and recovery of RPS were tested by Caco2. S9 assay suggested the metabolic mode of RPS in rats.Results: After oral administration of RPS, the metabolic compound like diosgenin was detected in different tissues although there was none in RPS. The concentration of PI, PII, PVI, PVII, PH and gracillin in the spleen was the highest among these organs. The content of diosgenin were the highest in lung and brain. Caco-2 test indicated that PI, PII, PVI and PVII were low permeability and low recovery. Efflux ratio indicated that PVI should be a potential P-gp substrate. Potential P-gp substrate may be PVI. S9 assay suggested that RPS possess slow metabolic and moderate metabolic compounds.Conclusions: Integrated LC?MS/MS analysis of serum samples, together with Caco-2 and S9 assays provided a theoretical basis for the application of RPS in the future.
版权所有 Copyright © 2002-2025 中国科学院昆明植物研究所,All Rights Reserved 【滇ICP备05000394号】
地址:中国云南省昆明市蓝黑路132号 邮政编码:650201 点击这里联系我们